Fondation Hopital Saint Joseph

Paris 21 trials 12 recruiting

21 Registered trials

12 Currently recruiting

Organisation

Fondation Hopital Saint Joseph

Location

Paris, France

Identifier

ORG-100054897

Address

185 Rue Raymond Losserand, 75014, France

Departments

75
Anesthesiology
Département de Microbiologie
Department of Radiology
FRA01-0: Oncology
Medical Oncology
n/a
Oncologie
Oncology
pneumo oncology and allergology department
Pneumo-oncologie et d’allergologie
Pneumo-oncology and Allergology Départment
Pneumology
Vascular medicine

Clinical trials at this site (21)

Search interface

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Uncomplicated candidemia 5
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
Impact of the timing of immunotherapy administration in metastatic lung cancers Pending

2025-521891-78-00 Adult patients with stage IV non squamous non-small cel 5
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or… Pending

2025-523461-17-01 LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANC 5
DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending

2025-523895-22-00 Non-small cell lung cancer (NSCLC) 4
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia after Distal Revascularization: a randomized, double-blind trial Pending

2025-524297-42-00 CLTI defined as Rutherford category 4 or 5 5
Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m… Pending

2025-524408-30-01 Metastatic hormone-sensitive prostate cancer 5
Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a… Pending

2025-525153-39-00 Chronic thromboembolic pulmonary hypertension 5
Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting

2025-522107-18-00 Locally advanced or metastatic Non-Small Cell Lung Canc 4 2026-05-19
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Recruiting

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting

2025-523686-15-00 Advanced or Metastatic Solid Tumors 1 2026-04-08
A Phase 1/2 Open Label Cohort Comparative Study Evaluating the Efficacy and the safety of Gene Therapy of the Sickle Cell Disease by Transpl… Recruiting

2025-521257-17-00 SCD severe patients 7 2026-02-25
Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting

2025-521805-41-00 Patients with HER2-positive, locally advanced or metast 5 2026-02-18
A Global Phase III Study of Puxitatug Samrotecan (AZD8205) Monotherapy Compared with Physician’s Choice of Chemotherapy for B7-H4-Selected E… Recruiting

2024-518777-34-00 B7-H4-Selected Advanced/Metastatic Endometrial Cancer. 5 2026-02-11
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or Af… Recruiting

2025-522400-24-00 Metastatic urothelial cancer 10 2026-01-27
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-11-24
A Phase 1b/2, Study of I-DXd in Combination with Atezolizumab with or without Carboplatin in First-line ES‑SCLC Recruiting

2023-509629-36-00 Extensive-stage Small Cell Lung Cancer (ES-SCLC) 9 2025-10-29
First-line immunotherapy-based standard of care and local ablative treatments for oligometastatic non-small cell lung cancer patients: a ran… Recruiting

2023-503326-39-00 Synchronous oligometastatic non-small cell lung cancer 5 2025-03-06
Gut microbiome intervention with EXL01 in combination with nivolumab and FOLFOX as first-line treatment for patients with PD-L1 CPS ≥5 metas… Recruiting

2023-506753-38-00 metastatic gastric adenocarcinoma 4 2024-04-16
STUDY OF OP-1250 ADMINSTERED AS MONOTHERAPY AND COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2– ADVANCED OR METASTATIC BREAST C… Recruiting

2023-505871-63-00 ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
PRODIGE 49 - OSCAR: Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 ± Irinotecan, and targeted therapy, in first… Ended

2024-518553-41-00 colon cancer and rectal with liver metastasis 5 2024-11-08